Alvarado, Gabriela
Salmen, Wilhelm http://orcid.org/0000-0003-0565-2852
Ettayebi, Khalil
Hu, Liya http://orcid.org/0000-0002-8340-8911
Sankaran, Banumathi http://orcid.org/0000-0002-3266-8131
Estes, Mary K. http://orcid.org/0000-0002-4813-4249
Venkataram Prasad, B. V. http://orcid.org/0000-0002-1172-2071
Crowe, James E. Jr. http://orcid.org/0000-0002-0049-1079
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (F31 Al129357)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32 GM120011)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1 TR002243)
Article History
Received: 7 December 2020
Accepted: 29 June 2021
First Online: 14 July 2021
Change Date: 14 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-021-26418-1
Competing interests
: M.K.E. is named as an inventor on patents related to cloning of the Norwalk virus genome, is a consultant to Takeda Vaccines, Inc and has received support from Takeda Vaccines, Inc. J.E.C. has served as a consultant for Luna Biologics, is a member of the Scientific Advisory Boards of Meissa Vaccines and is Founder of IDBiologics. The Crowe laboratory at Vanderbilt University Medical Center has received unrelated sponsored research agreements from Takeda, IDBiologics, and AstraZeneca.